Nantahala Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.19M Buy
5,144,114
+32,526
+0.6% +$28.2K 0.12% 117
2025
Q4
$6.03M Hold
5,111,588
0.2% 95
2025
Q3
$7.62M Hold
5,111,588
0.26% 84
2025
Q2
$9.92M Buy
5,111,588
+1,233,623
+32% +$1.61M 0.39% 54
2025
Q1
$4.73M Buy
3,877,965
+198,239
+5% +$487K 0.19% 76
2024
Q4
$11.1M Buy
3,679,726
+1,764,600
+92% +$4.96M 0.48% 40
2024
Q3
$4.85M Sell
1,915,126
-530,541
-22% -$1.89M 0.25% 74
2024
Q2
$11.5M Buy
2,445,667
+1,347,801
+123% +$7.1M 0.67% 31
2024
Q1
$6.22M Hold
1,097,866
0.36% 54
2023
Q4
$7.27M Buy
1,097,866
+641,774
+141% +$3.71M 0.43% 49
2023
Q3
$3.65M Buy
456,092
+100,000
+28% +$929K 0.31% 71
2023
Q2
$3.61M Buy
356,092
+100,000
+39% +$1.02M 0.35% 59
2023
Q1
$2.72M Sell
256,092
-92,910
-27% -$1.03M 0.21% 69
2022
Q4
$4.01M Hold
349,002
0.26% 57
2022
Q3
$2.97M Buy
+349,002
New +$2.89M 0.19% 63

Other funds holding TELA

Nantahala Capital Management's TELA Position: Q1 2026 in Review

Nantahala Capital Management increased its TELA Bio (TELA) stake by 0.64% in Q1 2026, buying an estimated $28.2K and bringing the position to 5,144,114 shares worth $3.19M. The position accounts for 0.12% of the portfolio, ranked #117.

Nantahala Capital Management first reported a position in TELA in Q3 2022 and has held it in 15 quarters since. The position peaked at $11.5M in Q2 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Nantahala Capital Management held 5,144,114 shares of TELA Bio worth $3.19M as of Q1 2026.
  • Nantahala Capital Management bought 32,526 TELA Bio shares in Q1 2026, an estimated $28.2K.
  • TELA Bio made up 0.12% of Nantahala Capital Management's portfolio in Q1 2026, its #117 holding.
  • Nantahala Capital Management first reported a position in TELA Bio in Q3 2022 and has held it in 15 quarters since.
  • Nantahala Capital Management's TELA Bio position peaked at $11.5M in Q2 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Nantahala Capital Management's 13F filing for Q1 2026, filed 15 May 2026.